CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67 | -74.3% | 18,269 | -75.0% | 0.01% | -73.1% |
| Q1 2023 | $261 | -51.4% | 73,111 | -61.2% | 0.03% | -61.2% |
| Q4 2022 | $537 | -99.9% | 188,308 | -12.9% | 0.07% | +4.7% |
| Q3 2022 | $482,000 | +49.2% | 216,250 | +66.8% | 0.06% | +33.3% |
| Q2 2022 | $323,000 | -31.4% | 129,666 | +34.3% | 0.05% | -23.8% |
| Q1 2022 | $471,000 | -58.3% | 96,563 | -3.3% | 0.06% | -55.6% |
| Q4 2021 | $1,129,000 | -36.4% | 99,816 | -18.0% | 0.14% | -21.5% |
| Q3 2021 | $1,774,000 | +436.0% | 121,727 | +328.7% | 0.18% | +389.2% |
| Q2 2021 | $331,000 | +113.5% | 28,396 | +124.2% | 0.04% | +42.3% |
| Q1 2021 | $155,000 | -80.7% | 12,666 | -80.3% | 0.03% | -80.3% |
| Q4 2020 | $804,000 | +19.3% | 64,297 | +43.5% | 0.13% | +17.9% |
| Q3 2020 | $674,000 | – | 44,801 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |